|
contents | america | ||||
| Medtech Insight 2009 In3 West Conference Medtech Insight, a division of Windhover Conferences, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that over 40 early- to late-stage companies are now confirmed to present at their upcoming "Investment In Innovation (In3) West" conference, being held March 2-4, 2009 at The Palazzo Resort ● Hotel ● Casino in Las Vegas, NV. Presentation timeslots are limited for this popular event, designed for those looking to partner, invest and network with the most promising start-up medical technology companies on course to impact the worldwide med device market. The two-day In3 West event – the company's 33rd In3 conference – will showcase 40+ highly promising start-up med device companies from around the world, presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Presenting companies (the majority presenting at an In3 event for the first time) from the U.S., Canada, Europe and Israel include Athena Feminine Technologies, Inc., Intralink-Spine (ILS), Silere Medical Technology, Inc., Audition Biotech LLC, Kuros Biosurgery, AG, Sleepvirtual, Bioheart, Inc., LifeWave, Inc., Soft Tissue Regeneration, Inc. , BioLineRx, Ltd., LineaGen, Inc., superDimension, Inc., Celerus Diagnostics, Inc., Mesynthes, Tagent, CVAC Systems, Inc., MicroTransponder, Inc., ThromboVision, Inc., CytoSorbents, Inc., Nanospectra Biosciences, Inc., TrueVision Systems Inc., Deep Vein Medical, NeoMend, Inc., Urovalve, Inc., Discovery Technology International, LLP, Nerites Corporation, Vertos Medical, Inc. e-Zassi, LLC, NuLens, Ltd., VG Innovations, LLC, FAST Diagnostics, PEAK Surgical, Inc., Victhom Human Bionics, Inc., Freedom Meditech Inc., pico-tesla Magnetic Therapies, LLC, ViOptix Inc., Genesis Medical Interventional, Inc., Polymedix, Inc., Zassi Medical Evolutions, LLC. Healionics Corporation, Prizm Medical, Inc., … among several others to be announced. Infopia USA, S.E.A. Medical Systems, Inc., Intellewave, LLC, Sensile Medical AG, Sequoia Medtech, Sherlock-NMD, The single-track In3 West format will include focused 10-minute presentations by a senior executive from each presenting company in one main ballroom; each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The program will feature an informative panel discussion that will take place on Tuesday morning, March 3, entitled "What are the Hot Deals Now and in the Future, " with panelists to include David Cassak, Managing Partner, Windhover Information (moderator), Tom Salemi, Staff Writer, IN VIVO, STARTUP (moderator), Jeani Delagardelle, Managing Director, New Leaf Venture Partners, Kevin Wasserstein, Managing Director, Versant Ventures, Annette Campbell-White, Senior Managing Member, MedVenture Associates and Trevor Moody, General Partner, Frazier Healthcare Ventures. A presenting company product exhibition and networking reception will take place on Tuesday evening. Second interactive panel will overview a "Financing Device Companies During Tough Economic Times: How I Learned to Love a Down Round" with panelists to include David Cassak, Managing Partner, Windhover Information (moderator), Stephen Levin, Executive Editor, FDC Windhover (moderator), Alan Kaganov, Partner, U.S. Venture Partners, Andrew Weiss, President and CEO, CoAxia, and Dan Sullivan, CEO, SuperDimension. In3 West co-sponsors include AdvaMed, Life Science Intelligence, MDMA, Medmarc and The Hartford, Germany Trade & Invest, The MedTech Group, Ronald Trahan Associates, Synectic Inc., and FDC Reports' The Gray Sheet. Visit www.windhover.com/in3west09 for regularly updated program details, and to download the event brochure. Medtech Insight and its parent company, Windhover Conferences, an Elsevier company, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1400 emerging medical technology company presenters and over 7500 attendees have participated at In3 events over the past 8 years. To secure your spot before the event sells out, contact one of the sales representatives below. Medtech Insight and Windhover Conferences will also hold the upcoming medtech investment and partnering events, "Investment In Innovation (In3) Europe" at the Marriott Rive Gauche Hotel in Paris, April 29-30, followed by "Investment In Innovation (In3) East" at The Westin Copley Place in Boston, MA, June 23-25. write your comments about the article :: © 2009 Exhibition News :: home page |